{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T06:55:14Z","timestamp":1648882514038},"reference-count":19,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2003,1,1]],"date-time":"2003-01-01T00:00:00Z","timestamp":1041379200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2003,1]]},"DOI":"10.1016\/j.thromres.2003.11.012","type":"journal-article","created":{"date-parts":[[2004,1,15]],"date-time":"2004-01-15T10:21:22Z","timestamp":1074162082000},"page":"131-135","source":"Crossref","is-referenced-by-count":6,"title":["Associated thrombophilic defects in essential thrombocythaemia: their relationship with clinical manifestations"],"prefix":"10.1016","volume":"112","author":[{"given":"L.I","family":"Kornblihtt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.G","family":"Heller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Correa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Casta\u00f1\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V","family":"Genoud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Vassallu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Sarano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Kordich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.C","family":"Molinas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2003.11.012_BIB1","first-page":"9","article-title":"Diagnostic criteria and prognosis in Polycythemia Vera and Essential Thrombocythemia","volume":"36","author":"Murphy","year":"1999","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.thromres.2003.11.012_BIB2","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1054\/blre.2001.0158","article-title":"Current opinion in essential thrombocythemia: pathogenesis, diagnosis and management","volume":"15","author":"Tefferi","year":"2001","journal-title":"Blood Rev."},{"key":"10.1016\/j.thromres.2003.11.012_BIB3","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1200\/JCO.1990.8.3.556","article-title":"Incidence and risk factors for thrombotic complications in a historical cohort of 100 patients with essential thrombocythemia","volume":"8","author":"Cortelazzo","year":"1990","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.thromres.2003.11.012_BIB4","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1365-2141.1993.tb08272.x","article-title":"Vascular complications of essential thrombocythemia: a link to cardiovascular risk factors","volume":"83","author":"Watson","year":"1993","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.thromres.2003.11.012_BIB5","first-page":"231","article-title":"Diez a\u00f1os de experiencia con anagrelide en el tratamiento de la trombocitemia esencial","volume":"62","author":"Kornblihtt","year":"2002","journal-title":"Medicina"},{"key":"10.1016\/j.thromres.2003.11.012_BIB6","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/369064a0","article-title":"Mutation in blood coagulation factor V associated with resistance to activated protein C","volume":"369","author":"Bertina","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.thromres.2003.11.012_BIB7","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.1182\/blood.V88.10.3698.bloodjournal88103698","article-title":"A common genetic variation in the 3\u2032 untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis","volume":"88","author":"Poort","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2003.11.012_BIB8","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/ng0595-111","article-title":"A candidate genetic risk factor for vascular disease: a common mutation in methylenentetrahydrofolate reductase","volume":"10","author":"Froost","year":"1995","journal-title":"Nat. Genet."},{"key":"10.1016\/j.thromres.2003.11.012_BIB9","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/j.1365-2141.1999.01340.x","article-title":"Homocysteine levels in polycythemia vera and essential thrombocythemia","volume":"105","author":"Gisslinger","year":"1999","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.thromres.2003.11.012_BIB10","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/ajh.10254","article-title":"Thrombophilic genotypes, natural anticoagulants, and plasma homocysteine in myeloproliferative disorders: relationship with splachnic vein thrombosis and arterial disease","volume":"72","author":"Amitrano","year":"2003","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.thromres.2003.11.012_BIB11","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/ajh.2830490404","article-title":"Low proteins C and S and activation of fibrinolysis in treated in essencial thombocythemia","volume":"49","author":"Wieczorek","year":"1995","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.thromres.2003.11.012_BIB12","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/ajh.10054","article-title":"Frequent occurrence of anticardiolipin antibodies, factor V Leiden mutation, and perturbed endothelial function in chronic myeloproliferative disorders","volume":"69","author":"Jensen","year":"2002","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.thromres.2003.11.012_BIB13","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/(SICI)1096-8652(199605)52:1<14::AID-AJH3>3.0.CO;2-9","article-title":"Reduction of antithrombin III, protein C, and protein S levels and activated protein C resistance in polycythemia vera and essential thrombocythemia patients with thrombosis","volume":"52","author":"Bucalossi","year":"1996","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.thromres.2003.11.012_BIB14","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1055\/s-0037-1613087","article-title":"Patients with essential thrombocythaemia have an increased prevalence of antiphospholipid antibodies which may be associated with thrombosis","volume":"87","author":"Harrison","year":"2002","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2003.11.012_BIB15","first-page":"471a","article-title":"Hemostatic gene polymorphisms and the prevalence of thrombohemorrahagic complications in polycythemia vera and essential thrombocythemia","volume":"98","author":"Afshai-Kharghan","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2003.11.012_BIB16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ajh.10153","article-title":"Factor V Leiden mutation carriership and venus thromboembolism in Polycythemia Vera and Essential Thrombocythemia","volume":"71","author":"Ruggieri","year":"2002","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.thromres.2003.11.012_BIB17","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0049-3848(00)00314-5","article-title":"Prevalence of three prothrombotic polymorphisms: factor V G1691A, factor II G20210A and methylenetetrahydrofolate reductase (MTHFR) C677T in Argentina","volume":"100","author":"Genoud","year":"2000","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2003.11.012_BIB18","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1161\/01.CIR.98.23.2520","article-title":"Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease. The result of a meta-analysis","volume":"98","author":"Bratstr\u00f6m","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2003.11.012_BIB19","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1182\/blood.V95.5.1517.005k48_1517_1532","article-title":"Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease","volume":"95","author":"Lane","year":"2000","journal-title":"Blood"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384803006807?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384803006807?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,29]],"date-time":"2020-03-29T03:02:12Z","timestamp":1585450932000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384803006807"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,1]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2003,1]]}},"alternative-id":["S0049384803006807"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2003.11.012","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2003,1]]}}}